trader_blues, Great analysis ! ! Yea.. Good Grief the market is so huge that just the spill-over from Tier 1, 2, and 3 will be at leas 1 billion in annual revenues...with 500 million of e- at a 10 pe thats 5 Billion in Market cap...now from where I sit that's at least a 10 bagger and thats conservative...Bears and shorts just aren't doing the math...OREX has a good balance of efacacy and safety ...It will be a top tier when approved soon...

YEP:
All the components of contrave and emptac have been well established for several years. Orex just improved them by offering a slower release which will achieve more of a linear dose which will only improve results.
The base drug of both contrave and emptac , Bupropion was invented in 1969!
My god, its probably been around longer than most of these shorts.
This is just bullet proof drugs that work great together.
I mean this is just a no brainier why do you think that director poured $10 mil probably almost all of his net worth into this.
Heck, I think I just talked myself into buying some more.